Optimal therapy for desmoid tumors: current options and challenges for the future
Mushriq Al-Jazrawe1,2, Magdalene Au1, Benjamin Alman1,3,2
1a 1 Hospital for Sick Children, Program in Developmental & Stem Cell Biology, Toronto, Ontario, Canada.
Expert Review of Anticancer Therapy
|October 17, 2015
Summary
Desmoid tumors, or aggressive fibromatosis, are rare neoplasms that require better understanding for effective management. Research is exploring their biology and treatment options to differentiate between tumors that stabilize and those that progress.
Area of Science:
- Oncology
- Neoplasms
- Tumor Biology
Background:
- Desmoid tumors, also known as aggressive fibromatosis, are rare, locally infiltrative neoplasms.
- These tumors arise from mutations activating β-catenin but do not metastasize.
- Their unpredictable presentation and behavior pose significant management challenges.
Purpose of the Study:
- To review recent findings in desmoid tumor biology.
- To discuss current and emerging treatment options for desmoid tumors.
- To highlight the need for better understanding of tumor behavior to guide management decisions.
Main Methods:
- Literature review of recent research on desmoid tumor biology.
- Analysis of current treatment modalities for desmoid tumors.
- Discussion of emerging management strategies, including watchful waiting.
Main Results:
- Desmoid tumors are characterized by β-catenin activation and local invasiveness.
- A wide array of treatments exist, including surgery, radiation, chemotherapy, and targeted therapies.
- Spontaneous stabilization in some cases supports watchful waiting as a viable option.
Conclusions:
- Understanding desmoid tumor biology is crucial for differentiating between tumors that may stabilize and those that require intervention.
- The emergence of watchful waiting necessitates improved methods for predicting tumor behavior.
- Further research into desmoid tumor pathogenesis and behavior is essential for optimizing patient care.
Related Concept Videos
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Inflammatory Bowel Disease V: Surgical Management
848
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
848


